AI Health Tech to Watch in Pharma With: Krish Ramadurai
Krish Ramadurai, Partner at AIX Ventures, shares insights into the most promising areas of AI-native health tech. From scalable AI diagnostics that combine multiple tests into one platform to full-stack biotech models that bypass inefficient CRO workflows, Ramadurai outlines how automation is reshaping pharma. He highlights opportunities in precision oncology, immunology, and lab automation, as well as the challenge of integrating disparate lab systems. The conversation points to a potential reinvention of big pharma, driven by efficiency gains, in-house automation, and strategic AI deployment.
Episode Contents:
About the Guest
Krish Ramadurai is a Partner at AIX Ventures, investing in AI-driven biotech and pharma innovations. Learn more at: https://www.linkedin.com/in/krishramadurai/
Key Takeaways
- AI-native diagnostics can scale value with multiple tests in one platform.
- Full-stack biotech models may replace inefficient CRO workflows.
- Automation and integration could reinvent big pharma operations.
Transcript Summary
What AI-native health tech trends should we watch?
Automation is moving into complex areas like diagnostics, image analysis, and clinical trials. Platforms like AI-native oncology diagnostics are stacking enterprise value by offering multiple tests and automating wet lab processes.
Will big pharma embrace automation?
Pharma wants in-house automation but struggles to integrate lab systems effectively. Full-stack biotech companies that control their data loops may capture more value than legacy CROs.
What's next?
Expect investments in precision oncology, immunology, and AI-enabled automation for lab workflows and clinical trials.
More Topics
- AI in Patient Care
- AI in the Healthcare Industry
- AI and Medical Innovation
- Healthcare Ethics and Policy
Keep Exploring
About the Series
AI and Healthcare—with Mika Newton and Dr. Sanjay Juneja is an engaging interview series featuring world-renowned leaders shaping the intersection of artificial intelligence and medicine.
Dr. Sanjay Juneja, a hematologist and medical oncologist widely recognized as “TheOncDoc,” is a trailblazer in healthcare innovation and a rising authority on the transformative role of AI in medicine.
Mika Newton is an expert in healthcare data management, with a focus on data completeness and universality. Mika is on the editorial board of AI in Precision Oncology and is no stranger to bringing transformative technologies to market and fostering innovation.